The electronic cigarette has divided the medical community. While promoted as a tool for smoking cessation, its use has opened a Pandora’s box. Evidence from studies on both cardiovascular and pulmonary health demonstrates that e-cigarettes are associated with multiple adverse effects. In this review, we specifically examine their consequences and associations with coronary artery disease, myocardial infarction, arrhythmias, arterial hypertension, and related conditions. Finally, we highlight approaches to counter the spread of these so-called harm-reduction alternatives, drawing on data from the European Respiratory Society, the European Society of Cardiology, and the Cochrane Collaboration.
Mihălțan et al. (Sun,) studied this question.